Cargando…
(584) Safety of Immunosuppression Maintenance in Heart Transplant Recipients with Covid-19: A Single Center Experience
PURPOSE: Heart transplant recipients are at a very high risk of adverse outcomes after SARS-CoV-2 infection. There is no clear guidance on how to manage immunosuppression (IS) on heart transplant patients with COVID-19; in most studies IS was decreased or held. At our center, however, we deliberatel...
Autores principales: | Amione Guerra, J., Guajardo, R., Kunavarapu, C., Kwan, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068106/ http://dx.doi.org/10.1016/j.healun.2023.02.599 |
Ejemplares similares
-
Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
por: Fuchs, Uwe, et al.
Publicado: (2012) -
Single center experience and early outcomes of Impella 5.5
por: Funamoto, Masaki, et al.
Publicado: (2023) -
Prevalence and Risk Factors of Immunosuppressant Nonadherence in Heart Transplant Recipients: A Single-Center Cross-Sectional Study
por: Zhang, Min, et al.
Publicado: (2019) -
584 Where Are They Now? - A Single-Center Survey of Burn Surgery Fellow Graduates
por: Prophete, Justine, et al.
Publicado: (2022) -
Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single‐center experience
por: Jáky‐Kováts, Zsuzsanna, et al.
Publicado: (2022)